New study shows common antibody therapy has anti-SARS-CoV-2 antibodies
Researchers at the University of Texas Medical Branch recently confirmed the presence of neutralizing antibodies to SARS-CoV-2 in a common subcutaneous antibody therapy (Hizentra) used to treat immunocompromised or immunodeficient ...
Apr 25, 2022
0
47